Your current location:Home > Services  > PHASE II-IV/IIS/PMS

In addition to providing BE/PD/PK/I phase CRO services, our company has also been providing long term II-IV services, post marketing clinical research (PMS), non intervention research (NIS) and research initiated by researchers (IIS) for the vast number of pharmaceutical companies.

We are able to provide clients with the implementation plan, clinical trial management and collaboration of clinical trials such as pharmaceuticals and medical devices.

Our project leader has a wealth of project management and project cooperation experience, able to effectively manage the project and accurately assess the risks of legislation and technology. We have established friendly cooperation with experts from several new drug research institutes and clinical research GCP base and Data Statistics Center in the country. In Beijing, Shanghai, Guangzhou, Chongqing, Changsha, Xi'an, Tianjin, Chengdu, Nanchang, Wuhan and other established our business service network construction system. We are deeply aware that the time, cost and quality of a new drug development are very important and important to enterprises. Therefore, we have established friendly communication with all research departments and relevant administrative departments of the country, and have carried out ingenious and humanized operation under the premise of ensuring quality and no violation, so as to ensure the smooth implementation of the project and provide strong registration applications. Force support.

Our technical team has participated in the field of research: cardiovascular, skin, endocrine, digestion, blood, tumor, anti infection, kidney disease, obstetrics and Gynecology, analgesia, rheumatism, urinary tract, and so on.



Our advantages:


(1) Standardized SOP, rich management experience, high-quality resources support, efficient operation of various clinical trials, shortening the clinical trial cycle.

(2) Relying on a scientific and rigorous project management system to determine the right research objectives, deploy the right strategies and resources, so as to achieve comprehensive and flexible management of clinical trials and obtain high-quality clinical research data.

(3) The clinical research service area is mainly about clinical research projects of chemical drugs and Chinese medicine, including 1 chemical drug, 2 new drugs, 3 new drugs of chemical drugs and 6 kinds of new drugs of Chinese medicine. The service covers cardiovascular, tumor, respiratory, digestive, endocrine, liver diseases, urinary, mental, ophthalmology, pediatrics, surgery, anesthesiology and other professional areas of drug treatment. The dosage forms include capsules, tablets, injections, and flushing fluid and so on.

 (4) To build a good research environment with Beijing An Zhen Hospital, Tiantan hospital, Peking University Cancer Hospital, Sichuan University, Peking University People's Hospital, Xi'an Jiao Tong University First Affiliated Hospital of Medical College, Sichuan University, and other top Chinese and western hospitals as well as top experts in different fields.